BioTech

Source: globenewswire.com The European Commission has given approval to Roche’s drug MabThera (rituximab). This drug helps treat adults with moderate to severe pemphigus vulgaris (PV),...

DUBLIN, March 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Ne

DowDuPont (DWDP) said that its board has approved the separation of DowDuPont's Materials Science Division, which will become the new Dow on April 1. In connection with the separation, the DowDuPont board of directors declared a pro rata dividend of all of the outstanding shares of common stock of Dow Inc.

TARRYTOWN, N.Y. and PARIS, March 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food an

TITUSVILLE, N.J., March 5, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administratio

Myonexus Therapeutics Announces Accelerated Acquisition by Sarepta Therapeutics Following Positive Preliminary Data from LGMD2E Program

NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Feb. 20, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc

ABBOTT PARK, Ill. and BAGSVÆRD, Denmark, Feb. 20, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Novo Nordisk today announced a non-exclusive partnershi

Source: globenewswire.com The U.S. Food and Drug Administration has accepted Roche’s Biologics License Application and granted Priority Review for polatuzumab vedotin in combination with bendamustine...

Source: globenewswire.com Novartis has received an approval from the US FDA for its drug, Egaten (triclabendazole). Egaten is used for the treatment of fascioliasis in...